Physician profile
Gary Mitchell Owens
NPI 1326334368
$403,712.02
in general payments reported to CMS, 2019-2025
27 companies · $31K in 2025
The $31K reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93K · 2020: $42K · 2021: $38K · 2022: $66K · 2023: $79K · 2024: $55K · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $149K · Travel and Lodging: $8,829 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,088 · Food and Beverage: $1,661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $149,367.08 |
| Travel and Lodging | $8,828.68 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,087.50 |
| Food and Beverage | $1,660.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $82,277.05 | 2019-2023 | Libtayo, Eylea |
| Genzyme Corporation | $60,164.46 | 2019-2025 | |
| Becton, Dickinson and Company | $35,800.00 | 2022-2024 | |
| Aerin Medical INC. | $28,700.00 | 2024-2025 | |
| Sanofi Pasteur INC. | $25,985.00 | 2020-2025 | |
| Genentech USA, INC. | $20,174.68 | 2023-2025 | Xolair |
| Eli Lilly and Company | $17,890.46 | 2019-2020 | |
| Emd Serono, INC. | $15,912.23 | 2019-2020 | |
| Horizon Therapeutics Plc | $13,787.50 | 2020-2022 | |
| Sage Therapeutics, LLC | $11,554.22 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $10,934.74 | 2019-2020 | |
| Seagen INC. | $8,200.00 | 2020 | |
| Cvrx, INC. | $8,000.00 | 2023 | Barostim Neo System |
| Pulmonx Corporation | $8,000.00 | 2022 | |
| Kyowa Kirin, INC. | $7,852.72 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $7,192.56 | 2019 | |
| Intersect Ent, INC. | $7,087.50 | 2020 | |
| Ge Healthcare | $6,690.00 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $6,652.14 | 2021-2022 | |
| Genentech, INC. | $4,652.38 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $4,637.07 | 2019 | |
| Optinose US, INC. | $4,323.44 | 2019 | |
| Janssen Global Services, LLC | $3,600.00 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $2,420.00 | 2019-2020 | |
| Abbvie INC. | $750.00 | 2020 | |
| Sobi, INC | $400.00 | 2024 | |
| Ocular Therapeutix, INC. | $73.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Owens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.